Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Heyman Richard A. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 4 Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 21,500 options to buy @ $5.59, valued at $120.2k
02/27/2023 4 Heyman Richard A. (Director) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 149,820 shares @ $0
Granted 37,407 shares @ $0
Granted 31,172 shares @ $0
Granted 20,657 options to buy @ $2.48, valued at $51.2k
09/06/2022 4 Heyman Richard A. (Director) has filed a Form 4 on Metacrine, Inc.
Txns: Granted 16,500 options to buy @ $0.42, valued at $6.9k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Granted 53,700 options to buy @ $3.75, valued at $201.4k
06/06/2022 4 Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 19,500 options to buy @ $13.56, valued at $264.4k
11/19/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns: Granted 19,000 options to buy @ $9.86, valued at $187.3k
09/16/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 706 shares @ $25.0511, valued at $17.7k
Sold 682 shares @ $25.0347, valued at $17.1k
09/14/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 479 shares @ $25.1005, valued at $12k
Sold 601 shares @ $25.0133, valued at $15k
09/09/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 1,086 shares @ $25.1125, valued at $27.3k
07/23/2021 4 Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 5,781 options to buy @ $28.33, valued at $163.8k
06/17/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Granted 16,625 options to buy @ $19.03, valued at $316.4k
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Metacrine, Inc.
Txns: Granted 16,500 options to buy @ $4.07, valued at $67.2k
05/24/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 700 shares @ $25.0829, valued at $17.6k
Sold 600 shares @ $25.25, valued at $15.2k
Sold 100 shares @ $25, valued at $2.5k
05/18/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 3,215 shares @ $25.3133, valued at $81.4k
Sold 498 shares @ $25.0679, valued at $12.5k
Sold 2,161 shares @ $25.3195, valued at $54.7k
05/13/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 100 shares @ $25.11, valued at $2.5k
04/30/2021 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 100 shares @ $25.08, valued at $2.5k
Sold 100 shares @ $25.26, valued at $2.5k
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2020 4 Heyman Richard A. (Director) has filed a Form 4 on YUMANITY THERAPEUTICS, INC.
Txns: Granted 6,158 shares @ $0
Granted 5,271 options to buy @ $8.16, valued at $43k
11/12/2020 4 Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 45,332 options to buy @ $4.22, valued at $191.3k
06/22/2020 4 Heyman Richard A. (Director) has filed a Form 4 on Gritstone Oncology, Inc.
Txns: Granted 12,500 options to buy @ $6.66, valued at $83.3k
04/28/2020 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Converted 62,500 shares @ $0
Converted 62,500 preferred shares @ $0
04/27/2020 4 Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Granted 16,625 options to buy @ $16, valued at $266k
06/20/2019 4 Heyman Richard A. (Director) has filed a Form 4 on Gritstone Oncology, Inc.
Txns: Granted 8,570 options to buy @ $10.86, valued at $93.1k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy